1 |
(r)-n-(5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1h-inden-1-yl)-1-methyl-1h-pyrazole-4-carboxamide |
Pyrazole |
- |
- |
- |
058 1件: 58 💬 |
2 |
1-(2,3,4-trimethoxybenzyl)piperazine dihydrochloride |
Piperazine |
6件: D00807 D00807, D01393 D01393, D02127 D02127, D02145 D02145, D05486 D05486, D06224 D06224 💬 |
- |
- |
058 1件: 58 💬 |
3 |
[myk-461] |
- |
- |
- |
- |
058 1件: 58 💬 |
4 |
Acetylcysteine |
Acetylcysteine |
1件: D00221 D00221 💬 |
- |
- |
006 16件: 6 , 13, 19, 20, 34, 49, 51, 58, 85, 94, 111, 164, 193, 233, 298, 299 💬 |
5 |
Adenosine |
Adenosine |
1件: D00045 D00045 💬 |
ADORA1 4件: ADORA1, ADORA2A, ADORA2B, ADORA3 💬 |
Alcoholism 12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 3件: 13, 58, 65 💬 |
6 |
Air |
- |
- |
- |
- |
003 7件: 3 , 51, 58, 85, 97, 193, 299 💬 |
7 |
Alcohol |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
013 4件: 13, 58, 279, 298 💬 |
8 |
Antiarrhythmic drugs |
- |
- |
- |
- |
058 1件: 58 💬 |
9 |
Atorvastatin |
Atorvastatin |
3件: D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬 |
10 |
Behavioral: lifestyle |
- |
- |
- |
- |
058 1件: 58 💬 |
11 |
Bluefish |
Bluefish |
- |
- |
- |
058 1件: 58 💬 |
12 |
Bnp |
- |
- |
- |
- |
046 2件: 46, 58 💬 |
13 |
Bnp blood sample test |
- |
- |
- |
- |
058 1件: 58 💬 |
14 |
Candesartan |
Candesartan |
1件: D00522 D00522 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
058 2件: 58, 67 💬 |
15 |
Carnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
005 8件: 5 , 13, 58, 96, 97, 265, 298, 316 💬 |
16 |
Cas name: 1,4-benzoxazepin-5(2h)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4- (trifluoromethoxy)phenyl] iupac name: 4-(pyrimidin-2-ylmethyl)-7-[4- (trifluoromethoxy)phenyl]-3,4-dihydro-1,4-benzoxazepin-5(2h)-one |
- |
- |
- |
- |
058 1件: 58 💬 |
17 |
Cas name: 1,4-benzoxazepin-5(2h)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4-(trifluoromethoxy)phenyl] iupac name: 4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethoxy)phenyl]-3,4-dihydro-1,4-benzoxazepin-5(2h)-one |
- |
- |
- |
- |
058 1件: 58 💬 |
18 |
Ck-3773274 |
- |
- |
- |
- |
058 1件: 58 💬 |
19 |
Ck-3773274 (10 - 30 mg) |
- |
- |
- |
- |
058 1件: 58 💬 |
20 |
Ck-3773274 (5 - 15 mg) |
- |
- |
- |
- |
058 1件: 58 💬 |
21 |
Ck-3773274 - granules in capsule |
- |
- |
- |
- |
058 1件: 58 💬 |
22 |
Ck-3773274 - tablets |
- |
- |
- |
- |
058 1件: 58 💬 |
23 |
Ct-g20 |
- |
- |
- |
- |
058 1件: 58 💬 |
24 |
Cufence |
- |
- |
- |
- |
058 1件: 58 💬 |
25 |
Cyclosporine |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 35件: 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 63, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬 |
26 |
Cyclosporine a |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
019 10件: 19, 20, 36, 49, 50, 53, 58, 60, 234, 283 💬 |
27 |
Device: insertable cardiac monitor |
Methamidophos |
- |
- |
- |
058 1件: 58 💬 |
28 |
Device: magnetic resonance imaging (mri) with gadolinium enhancement |
Gadolinium |
- |
- |
- |
058 1件: 58 💬 |
29 |
Device: magnetic resonance imaging (mri) without gadolinium enhancement |
Gadolinium |
- |
- |
- |
058 1件: 58 💬 |
30 |
Device: use of bioanalytical assay to monitor plasma levels of perhexiline |
Methamidophos |
2件: D05442 D05442, D08340 D08340 💬 |
CACNA1C 8件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, CPT1A, CPT1B, CPT1C, CPT2 💬 |
AMPK signaling pathway 45件: AMPK signaling pathway, Adipocytokine signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, Fatty acid degradation, Fatty acid metabolism, GABAergic synapse, Glucagon signaling pathway, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin resistance, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, PPAR signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Thermogenesis, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
058 1件: 58 💬 |
31 |
Diagnostic test: air venous plethysmography |
- |
- |
- |
- |
058 1件: 58 💬 |
32 |
Diagnostic test: echocardiography |
- |
- |
- |
- |
058 1件: 58 💬 |
33 |
Diagnostic test: electrocardiogram |
- |
- |
- |
- |
058 1件: 58 💬 |
34 |
Diagnostic test: exercise stress transthoracic echocardiogram |
- |
- |
- |
- |
058 1件: 58 💬 |
35 |
Diagnostic test: holter ecg |
- |
- |
- |
- |
058 1件: 58 💬 |
36 |
Diagnostic test: phosphorous magnetic resonance spectroscopy |
Phosphorus |
- |
- |
- |
058 1件: 58 💬 |
37 |
Diagnostic test: upper member arterial doppler echography with analysis of fmd |
- |
- |
- |
- |
058 1件: 58 💬 |
38 |
Diltiazem |
Diltiazem |
3件: D00616 D00616, D03830 D03830, D07845 D07845 💬 |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 3件: 51, 58, 86 💬 |
39 |
Diovan |
- |
- |
- |
- |
058 1件: 58 💬 |
40 |
Diovan 160 mg |
- |
- |
- |
- |
058 1件: 58 💬 |
41 |
Diovan 40 mg |
- |
- |
- |
- |
058 1件: 58 💬 |
42 |
Diovan 80 mg |
- |
- |
- |
- |
058 1件: 58 💬 |
43 |
Dobutamine |
Dobutamine |
4件: D00632 D00632, D03879 D03879, D03880 D03880, D03881 D03881 💬 |
ADRB1 1件: ADRB1 💬 |
Adrenergic signaling in cardiomyocytes 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
057 3件: 57, 58, 215 💬 |
44 |
Echo and myocardial contrast echocardiography perfusion imaging |
- |
- |
- |
- |
058 1件: 58 💬 |
45 |
Eleclazine |
Eleclazine |
1件: D11155 D11155 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
058 1件: 58 💬 |
46 |
Endothelial function biomarkers |
- |
- |
- |
- |
058 1件: 58 💬 |
47 |
Entresto |
- |
- |
- |
- |
058 1件: 58 💬 |
48 |
Gadolinium |
Gadolinium |
- |
- |
- |
013 6件: 13, 34, 46, 58, 65, 86 💬 |
49 |
Gradient |
- |
- |
- |
- |
058 4件: 58, 86, 149, 215 💬 |
50 |
Gs-6615 3 mg |
- |
- |
- |
- |
058 1件: 58 💬 |
51 |
Gs-6615 3 mg pink |
- |
- |
- |
- |
058 1件: 58 💬 |
52 |
Gs-6615 3 mg white |
- |
- |
- |
- |
058 1件: 58 💬 |
53 |
Gs-6615 6 mg |
- |
- |
- |
- |
058 1件: 58 💬 |
54 |
Gs-6615 6 mg white |
- |
- |
- |
- |
058 1件: 58 💬 |
55 |
Gutron 2,5mg |
- |
- |
- |
- |
058 1件: 58 💬 |
56 |
Gutron 5mg |
- |
- |
- |
- |
058 1件: 58 💬 |
57 |
Hyperpolarized 13c-pyruvate |
- |
- |
- |
- |
058 1件: 58 💬 |
58 |
Lcz696 |
- |
- |
- |
- |
058 1件: 58 💬 |
59 |
Lcz696 100 mg |
- |
- |
- |
- |
058 1件: 58 💬 |
60 |
Lcz696 200 mg |
- |
- |
- |
- |
058 1件: 58 💬 |
61 |
Lcz696 50 mg |
- |
- |
- |
- |
058 1件: 58 💬 |
62 |
Losartan |
Losartan |
2件: D00357 D00357, D08146 D08146 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
63 |
Losartan bluefish 50 mg |
Bluefish |
2件: D00357 D00357, D08146 D08146 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
058 1件: 58 💬 |
64 |
Mangafodipir |
Mangafodipir |
1件: D08262 D08262 💬 |
- |
- |
013 2件: 13, 58 💬 |
65 |
Mavacamten |
Mavacamten |
- |
- |
- |
058 1件: 58 💬 |
66 |
Mek162 |
- |
- |
- |
- |
058 2件: 58, 195 💬 |
67 |
Metoprolol |
Metoprolol |
3件: D00601 D00601, D02358 D02358, D05011 D05011 💬 |
ADRB1 1件: ADRB1 💬 |
Adrenergic signaling in cardiomyocytes 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 6件: 17, 57, 58, 113, 193, 226 💬 |
68 |
Metoprolol succinate |
Metoprolol |
3件: D00601 D00601, D02358 D02358, D05011 D05011 💬 |
ADRB1 1件: ADRB1 💬 |
Adrenergic signaling in cardiomyocytes 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
057 4件: 57, 58, 113, 193 💬 |
69 |
Midodrine |
Midodrine |
2件: D01307 D01307, D08220 D08220 💬 |
ADRA1A 3件: ADRA1A, ADRA1B, ADRA1D 💬 |
AMPK signaling pathway 7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
006 3件: 6 , 17, 58 💬 |
70 |
Midodrine hydrochloride |
Midodrine |
2件: D01307 D01307, D08220 D08220 💬 |
ADRA1A 3件: ADRA1A, ADRA1B, ADRA1D 💬 |
AMPK signaling pathway 7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
058 1件: 58 💬 |
71 |
Monitor |
Methamidophos |
- |
- |
- |
002 18件: 2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬 |
72 |
Myk-461 |
- |
- |
- |
- |
058 1件: 58 💬 |
73 |
N-acetylcysteine |
Acetylcysteine |
1件: D00221 D00221 💬 |
- |
- |
006 10件: 6 , 13, 19, 20, 49, 58, 85, 111, 164, 299 💬 |
74 |
Nitrate |
Nitrate |
1件: D02313 D02313 💬 |
- |
- |
058 3件: 58, 113, 299 💬 |
75 |
Other: exercise echocardiography |
- |
- |
- |
- |
058 1件: 58 💬 |
76 |
Other: mangafodipir trisodium |
Mangafodipir |
1件: D08262 D08262 💬 |
- |
- |
058 1件: 58 💬 |
77 |
Other: walk distance test |
- |
- |
- |
- |
058 1件: 58 💬 |
78 |
Perhexiline |
Perhexiline |
2件: D05442 D05442, D08340 D08340 💬 |
CACNA1C 8件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, CPT1A, CPT1B, CPT1C, CPT2 💬 |
AMPK signaling pathway 45件: AMPK signaling pathway, Adipocytokine signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, Fatty acid degradation, Fatty acid metabolism, GABAergic synapse, Glucagon signaling pathway, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin resistance, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, PPAR signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Thermogenesis, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
058 2件: 58, 272 💬 |
79 |
Perxexiline |
- |
- |
- |
- |
058 1件: 58 💬 |
80 |
Pexsig |
- |
- |
- |
- |
058 1件: 58 💬 |
81 |
Phosphorous |
Phosphorus |
- |
- |
- |
058 1件: 58 💬 |
82 |
Piperazine |
Piperazine |
6件: D00807 D00807, D01393 D01393, D02127 D02127, D02145 D02145, D05486 D05486, D06224 D06224 💬 |
- |
- |
058 1件: 58 💬 |
83 |
Pirfenidone |
Pirfenidone |
1件: D01583 D01583 💬 |
CCL2 6件: CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 82件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
034 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬 |
84 |
Procedure: 3d electrocardiographic mapping (ecm) |
- |
- |
- |
- |
058 1件: 58 💬 |
85 |
Procedure: b-lines se |
- |
- |
- |
- |
058 3件: 58, 86, 215 💬 |
86 |
Procedure: coronary flow reserve se |
- |
- |
- |
- |
058 3件: 58, 86, 215 💬 |
87 |
Procedure: diastolic function se |
- |
- |
- |
- |
058 3件: 58, 86, 215 💬 |
88 |
Procedure: echocardiography (tee) |
- |
- |
- |
- |
058 1件: 58 💬 |
89 |
Procedure: left ventricular contractile reserve se |
- |
- |
- |
- |
058 3件: 58, 86, 215 💬 |
90 |
Procedure: left ventricular outflow tract gradient se |
- |
- |
- |
- |
058 3件: 58, 86, 215 💬 |
91 |
Procedure: mitral regurgitation se |
- |
- |
- |
- |
058 3件: 58, 86, 215 💬 |
92 |
Procedure: pulmonary hemodynamics se |
- |
- |
- |
- |
058 3件: 58, 86, 215 💬 |
93 |
Procedure: rf catheter ablation |
- |
- |
- |
- |
058 1件: 58 💬 |
94 |
Procedure: trans-right ventricular alcohol septal ablation (trvasa) |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
058 1件: 58 💬 |
95 |
Pyrazole |
Pyrazole |
- |
- |
- |
058 1件: 58 💬 |
96 |
Ranexa |
- |
- |
- |
- |
058 1件: 58 💬 |
97 |
Ranexa*60cpr 500mg r.p. |
- |
- |
- |
- |
058 1件: 58 💬 |
98 |
Ranexa*60cpr 750mg r.p. |
- |
- |
- |
- |
058 1件: 58 💬 |
99 |
Ranolazine |
Ranolazine |
2件: D05700 D05700, D05701 D05701 💬 |
- |
- |
002 6件: 2 , 58, 86, 96, 113, 114 💬 |
100 |
Ranolazine 1000 mg pr tablets |
Ranolazine |
2件: D05700 D05700, D05701 D05701 💬 |
- |
- |
058 1件: 58 💬 |
101 |
Ranolazine 500 mg pr tablets |
Ranolazine |
2件: D05700 D05700, D05701 D05701 💬 |
- |
- |
058 1件: 58 💬 |
102 |
Ranolazine 750 mg pr tablets |
Ranolazine |
2件: D05700 D05700, D05701 D05701 💬 |
- |
- |
058 1件: 58 💬 |
103 |
Ranolazine pr (prolonged-release) 500 mg 1 tablet bis in die and 750 mg 1 tablet bis in die |
Ranolazine |
2件: D05700 D05700, D05701 D05701 💬 |
- |
- |
058 1件: 58 💬 |
104 |
Regadenoson |
Regadenoson |
1件: D05711 D05711 💬 |
ADORA2A 1件: ADORA2A 💬 |
Alcoholism 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
058 1件: 58 💬 |
105 |
Sacubitril |
Sacubitril |
1件: D10225 D10225 💬 |
MME 1件: MME 💬 |
Alzheimer disease 4件: Alzheimer disease, Hematopoietic cell lineage, Protein digestion and absorption, Renin-angiotensin system |
058 1件: 58 💬 |
106 |
Sacubitril valsartan |
Sacubitril |
2件: D00400 D00400, D10225 D10225 💬 |
AGTR1 2件: AGTR1, MME 💬 |
AGE-RAGE signaling pathway in diabetic complications 19件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hematopoietic cell lineage, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Protein digestion and absorption, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
058 1件: 58 💬 |
107 |
Sacubitril/valsartan |
Sacubitril |
2件: D00400 D00400, D10225 D10225 💬 |
AGTR1 2件: AGTR1, MME 💬 |
AGE-RAGE signaling pathway in diabetic complications 19件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hematopoietic cell lineage, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Protein digestion and absorption, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
058 1件: 58 💬 |
108 |
Sodium nitrate |
Nitrate |
1件: D02313 D02313 💬 |
- |
- |
058 2件: 58, 113 💬 |
109 |
Spironolactone |
Spironolactone |
1件: D00443 D00443 💬 |
NR3C2 1件: NR3C2 💬 |
Aldosterone-regulated sodium reabsorption 1件: Aldosterone-regulated sodium reabsorption |
058 7件: 58, 67, 86, 113, 210, 218, 225 💬 |
110 |
Treatment bx1514m |
- |
- |
- |
- |
058 1件: 58 💬 |
111 |
Trientine |
Triethylenetetramine |
- |
- |
- |
058 2件: 58, 171 💬 |
112 |
Trientine dihydrochloride |
Triethylenetetramine |
- |
- |
- |
058 2件: 58, 171 💬 |
113 |
Triethylinetetramine dihydrochloride |
- |
- |
- |
- |
058 1件: 58 💬 |
114 |
Trimetazidine |
Trimetazidine |
2件: D01606 D01606, D08642 D08642 💬 |
- |
- |
058 2件: 58, 86 💬 |
115 |
Trimetazidine dihydrochloride |
Trimetazidine |
2件: D01606 D01606, D08642 D08642 💬 |
- |
- |
058 1件: 58 💬 |
116 |
Trimetazidine dihydrochloride 20mg |
Trimetazidine |
2件: D01606 D01606, D08642 D08642 💬 |
- |
- |
058 1件: 58 💬 |
117 |
Valsartan |
Valsartan |
1件: D00400 D00400 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
057 7件: 57, 58, 66, 75, 218, 222, 224 💬 |
118 |
Vastarel |
- |
- |
- |
- |
058 1件: 58 💬 |
119 |
Vastarel 20mg film coated tablets |
- |
- |
- |
- |
058 1件: 58 💬 |